Literature DB >> 2556492

Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection.

A E Ades1, C S Peckham, G E Dale, J M Best, S Jeansson.   

Abstract

There has been a recent increase in notifications of genital herpes but it is not known whether this has been reflected in the pregnant population. We have therefore carried out a study to determine the prevalence of herpes simplex antibodies in pregnant women and to estimate the incidence of primary infection. Sera were collected from 3533 women at antenatal clinics and tested for total antibodies to herpes simples virus (HSV), and if positive, for specific antibodies to HSV-2. Estimates of HSV-1 seroprevalence were derived from the HSV-2 seronegative population. HSV-1 seroprevalence was nearly 100% in black women born in Africa or the Caribbean and 60-80% in white, Asian and UK born black women. It was lower in women in non-manual employment. HSV-2 seroprevalence was related to age, rising from 0 at age 16 to 40% at age 35 in black women, and to about 10% in Asian and white women. The estimated incidence of primary HSV-2 infection during pregnancy, per 1000 pregnancies, was about 2.4 in Asian women, 5 in white women, and 20 in black women. Estimates of the incidence of neonatal infection were derived from these figures and compared to the nationally reported rates.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2556492      PMCID: PMC1052791          DOI: 10.1136/jech.43.1.53

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  27 in total

1.  Sexual and socioeconomic factors affecting the risk of past infections with herpes simplex virus type 2.

Authors:  K M Stavraky; W E Rawls; J Chiavetta; A P Donner; J M Wanklin
Journal:  Am J Epidemiol       Date:  1983-07       Impact factor: 4.897

2.  The estimation of age-related rates of infection from case notifications and serological data.

Authors:  B T Grenfell; R M Anderson
Journal:  J Hyg (Lond)       Date:  1985-10

3.  Herpes simplex virus type-selective enzyme-linked immunosorbent assay with Helix pomatia lectin-purified antigens.

Authors:  B Svennerholm; S Olofsson; S Jeansson; A Vahlne; E Lycke
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

4.  Reasons for the absence of a history of recurrent genital infections in mothers of neonates infected with herpes simplex virus.

Authors:  A S Yeager; A M Arvin
Journal:  Pediatrics       Date:  1984-02       Impact factor: 7.124

5.  Sex partners and herpes simplex virus type 2 in the epidemiology of cancer of the cervix.

Authors:  S Graham; W Rawls; M Swanson; J McCurtis
Journal:  Am J Epidemiol       Date:  1982-05       Impact factor: 4.897

6.  A simple model relevant to toxoplasmosis applied to epidemiologic results in France.

Authors:  L Papoz; F Simondon; W Saurin; H Sarmini
Journal:  Am J Epidemiol       Date:  1986-01       Impact factor: 4.897

7.  Cytomegalovirus infection in pregnancy: preliminary findings from a prospective study.

Authors:  C S Peckham; K S Chin; J C Coleman; K Henderson; R Hurley; P M Preece
Journal:  Lancet       Date:  1983-06-18       Impact factor: 79.321

8.  Relationship of antibody to outcome in neonatal herpes simplex virus infections.

Authors:  A S Yeager; A M Arvin; L J Urbani; J A Kemp
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

9.  Persistence of serum IgA antibodies to herpes simplex, varicella-zoster, cytomegalovirus, and rubella virus detected by enzyme-linked immunosorbent assays.

Authors:  G E Morris; R M Coleman; J M Best; B B Benetato; A J Nahmias
Journal:  J Med Virol       Date:  1985-08       Impact factor: 2.327

10.  Evaluation of solubilized herpes simplex virus membrane antigen by enzyme-linked immunosorbent assay.

Authors:  S Jeansson; M Forsgren; B Svennerholm
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

View more
  19 in total

Review 1.  Improving the care of patients with genital herpes.

Authors:  S Drake; S Taylor; D Brown; D Pillay
Journal:  BMJ       Date:  2000-09-09

2.  Neonatal herpes prevention: a minor public health problem in some communities.

Authors:  A Mindel; J Taylor; R L Tideman; C Seifert; G Berry; K Wagner; J Page; C Marks; B Trudinger; A Cunningham
Journal:  Sex Transm Infect       Date:  2000-08       Impact factor: 3.519

3.  Methods for estimating the incidence of primary infection in pregnancy: a reappraisal of toxoplasmosis and cytomegalovirus data.

Authors:  A E Ades
Journal:  Epidemiol Infect       Date:  1992-04       Impact factor: 2.451

4.  Evaluation of five commercial assays for screening antenatal sera for antibodies to Toxoplasma gondii.

Authors:  W D Cubitt; A E Ades; C S Peckham
Journal:  J Clin Pathol       Date:  1992-05       Impact factor: 3.411

5.  Maternal and fetal screening.

Authors: 
Journal:  BMJ       Date:  1990-06-09

6.  The international development of the RGHQoL: a quality of life measure for recurrent genital herpes.

Authors:  L C Doward; S P McKenna; T Kohlmann; M Niero; D Patrick; B Spencer; H Thorsen
Journal:  Qual Life Res       Date:  1998-02       Impact factor: 4.147

Review 7.  The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report. The EU Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Cinque; G M Cleator; T Weber; P Monteyne; C J Sindic; A M van Loon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

Review 8.  Sexually transmitted diseases in children: herpes simplex virus infection, cytomegalovirus infection, hepatitis B virus infection and molluscum contagiosum.

Authors:  A Nageswaran; G R Kinghorn
Journal:  Genitourin Med       Date:  1993-08

9.  Prevalence of infection with herpes simplex virus types 1 and 2 in Australia: a nationwide population based survey.

Authors:  A L Cunningham; R Taylor; J Taylor; C Marks; J Shaw; A Mindel
Journal:  Sex Transm Infect       Date:  2006-04       Impact factor: 3.519

10.  Longitudinal study of Toxoplasma seroprevalence in South Yorkshire.

Authors:  J Walker; D J Nokes; R Jennings
Journal:  Epidemiol Infect       Date:  1992-02       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.